Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peter Marks
Fierce Biotech
Former FDA official Peter Marks joins Eli Lilly
Six months after his departure from the federal government, Peter Marks, M.D., Ph.D., has joined Eli Lilly.
Darren Incorvaia
,
Eric Sagonowsky
Oct 7, 2025 3:49pm
FDA's acting CDER head heads for the exit: report
Jun 23, 2025 1:48pm
Ex-CBER chief says FDA layoffs threaten future drug reviews: BMO
Apr 17, 2025 2:55pm
RFK Jr. eyes changes to US vaccine safety reporting system: Stat
Apr 16, 2025 11:45am
Former CBER head Peter Marks details forced exit from FDA: AP
Apr 8, 2025 5:20pm
FDA misses decision deadline for Novavax COVID vaccine
Apr 3, 2025 3:28pm